Global Synthetic Biology Market Research 2024-2035: The Bioeconomy's Transformation - An Industry on the Brink of Revolution with profiles of 295+ Companies
29 avr. 2024 04h43 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "The Global Market for Synthetic Biology 2024-2035" report has been added to ResearchAndMarkets.com's offering. This report is an essential resource...
Regenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033
26 avr. 2024 11h10 HE
|
Precedence Research
Ottawa, April 26, 2024 (GLOBE NEWSWIRE) -- According to Precedence Research, the global regenerative medicine market size is calculated at USD 35.82 billion in 2024. Regenerative medicines are used...
Longeveron to Present at the Planet MicroCap Showcase
25 avr. 2024 16h05 HE
|
Longeveron
Longeveron to present at investor conference - Planet MicroCap Showcase - May 1, 2024.
Cell Cryopreservation - Global Market Analysis to 2030 Featuring Profiles of Merck, Thermo Fisher Scientific, Sartorius, PromoCell, and Lonza Group
25 avr. 2024 10h28 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Cryopreservation Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's...
Global Cell Expansion Market Landscape 2024-2029 Featuring Analysis of Thermo Fisher Scientific, Danaher Corp, Merck, Sartorius, Corning, and More
19 avr. 2024 04h05 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Expansion Market Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.The global cell expansion market is...
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
17 avr. 2024 08h00 HE
|
Longeveron
Longeveron raises gross proceeds of ~$6.2 M from exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its common stock.
Longeveron Announces Closing of $5.2 Million Public Offering
11 avr. 2024 17h17 HE
|
Longeveron
Longeveron announces closing of previously announced public offering, raising $5.25 million in gross proceeds.
3D Cell Culture Report 2024: 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
08 avr. 2024 08h53 HE
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "3D Cell Culture - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for 3D Cell Culture...
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
08 avr. 2024 08h30 HE
|
Longeveron
CEO Letter to Shareholders. Update on overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.
Life Science Tools Global Strategic Research Report 2024: Market to Reach $258.6 Billion by 2030 - Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
05 avr. 2024 09h19 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Life Science Tools - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Life Science Tools Market to...